Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
Clinical trial NCT01960829 · UNKNOWN
Trial details
- NCT number
- NCT01960829
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.